22.01.2024 - ZUG, Switzerland, and BOSTON, Jan. 22, 2024 (GLOBE NEWSWIRE) - Oculis Holding AG (Nasdaq: OCS) (“Oculis” or “the Company”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced it will host an . Seite 1
/PRNewswire/ Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of.